Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03817775
Other study ID # MusicSeda
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 31, 2019
Est. completion date April 3, 2019

Study information

Verified date October 2019
Source Association de Musicothérapie Applications et Recherches Cliniques
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a non-blinded, non-randomized controlled pilot study with no follow-up. Patients will be recruited from the coronary angiography patient pool of the American Hospital of Paris and assigned to one of 2 groups in a non-randomized manner.


Description:

This is a non-blinded, non-randomized controlled pilot study with patients who will be followed during their coronary angiography procedure and with no follow-up. Patients will be recruited from the coronary angiography patient pool of the American Hospital of Paris and assigned to one of 2 groups in a non-randomized manner. It is expected to enroll around 100 patients and this is estimated to be obtained in a period of 2 months approximately. Patients will be placed in the control group, without music intervention, or assigned to the music group. Assignment will be done in this manner due to limited availability of the hardware and software to the investigation team. Patients in both groups will be matched based on age, sex, weight, height, American Society of Anesthesiology (ASA) score, and prior medical history, including diabetes, hypertension, chronic kidney disease and stroke. Each patient will receive a standardized sedation in the traditional manner and at the discretion of the investigator to reach Bispectral index (BIS) score below 90 and sedation score ≤ 1. The primary study end points will be the consumptions in analgesics and hypnotics. Secondary study end points will be pain and anxiety scores as measured the Numeric Rating Scale (NRS), the Visual Analog Scale (VAS) and the Amsterdam Preoperative Anxiety and Information Scale (APAIS).


Recruitment information / eligibility

Status Completed
Enrollment 76
Est. completion date April 3, 2019
Est. primary completion date April 3, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient needs a coronary angiography

- Patient gives verbal consent to participation in the study.

Exclusion Criteria:

- Patient aged less than 18 years at time of enrollment

- Patient doesn't like music for cultural reason

- Patient with serious psychiatric disorders

- Patient with not paired deafness or paired one with devices that are incompatible with wearing a headset.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Music therapy
The intervention group will administer "U" sequence between 10 minutes prior to the beginning of the procedure until its end.

Locations

Country Name City State
France American Hospital of Paris Neuilly-sur-Seine

Sponsors (2)

Lead Sponsor Collaborator
Association de Musicothérapie Applications et Recherches Cliniques American Hospital of Paris

Country where clinical trial is conducted

France, 

References & Publications (4)

Guétin S, Brun L, Deniaud M, Clerc JM, Thayer JF, Koenig J. Smartphone-based Music Listening to Reduce Pain and Anxiety Before Coronarography: A Focus on Sex Differences. Altern Ther Health Med. 2016 Jul;22(4):60-3. — View Citation

Guétin S, Giniès P, Siou DK, Picot MC, Pommié C, Guldner E, Gosp AM, Ostyn K, Coudeyre E, Touchon J. The effects of music intervention in the management of chronic pain: a single-blind, randomized, controlled trial. Clin J Pain. 2012 May;28(4):329-37. doi: 10.1097/AJP.0b013e31822be973. — View Citation

Jaber S, Bahloul H, Guétin S, Chanques G, Sebbane M, Eledjam JJ. [Effects of music therapy in intensive care unit without sedation in weaning patients versus non-ventilated patients]. Ann Fr Anesth Reanim. 2007 Jan;26(1):30-8. Epub 2006 Nov 3. French. — View Citation

Messika J, Hajage D, Panneckoucke N, Villard S, Martin Y, Renard E, Blivet A, Reignier J, Maquigneau N, Stoclin A, Puechberty C, Guétin S, Dechanet A, Fauquembergue A, Gaudry S, Dreyfuss D, Ricard JD. Effect of a musical intervention on tolerance and efficacy of non-invasive ventilation in the ICU: study protocol for a randomized controlled trial (MUSique pour l'Insuffisance Respiratoire Aigue - Mus-IRA). Trials. 2016 Sep 13;17(1):450. doi: 10.1186/s13063-016-1574-z. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Dose Use of Midazolam Medication (mg) The consumption in Midazolam medication was reported during the coronary angioplasty. Dose was in mg. Between 10 minutes prior to the beginning of the procedure up to 45 minutes.
Primary Dose Use of Propofol Medication (mg) The consumption in Propofol medication was reported during the coronary angioplasty. Dose was in mg. Between 10 minutes prior to the beginning of the procedure up to 45 minutes.
Primary Dose Use of Sufentanil Medication (ug) The consumption in Sufentanil medication was reported during the coronary angioplasty. Dose was in ug. Between 10 minutes prior to the beginning of the procedure up to 45 minutes.
Secondary Pain Score Pain score was measured using the Visual Analog Scale (VAS). This scale ranged from 0 (no pain) to 10 (very high pain), and collected the maximum pain the patient had during the procedure. This was collected right after the end of the procedure in the recovery room. From 0 up to 45 minutes.
Secondary Anxiety Score (NRS) Anxiety score was measured using the Numeric Rating Scale (NRS). This scale ranged from 0 (no anxiety) to 10 (very high anxiety), and collected the maximum anxiety the patient had during the procedure. This was collected right after the end of the procedure in the recovery room. From 0 up to 45 minutes.
Secondary Satisfaction of the Patient Satisfaction was measured using a scale from 0 to 5, with a higher score for a high satisfaction. Right after the end of the procedure in the recovery room.
Secondary Effect on Physiological Parameters: BIS Bispectral index (BIS) score at baseline which corresponds to 10 minutes before the beginning of the procedure.
The BIS monitor provides a single dimensionless number which ranges from 0 (equivalent to EEG silence) to 100. Higher is the score, better it is.
10 minutes prior to the beginning of the procedure
Secondary Effect on Physiological Parameters: Heart Rate Heart rate at Baseline which corresponds to 10 minutes before the beginning of the procedure. 10 minutes prior to the beginning of the procedure.
Secondary Effect on Physiological Parameters: SpO2% SpO2 at Baseline which corresponds to 10 minutes before the beginning of the procedure.. 10 minutes prior to the beginning of the procedure.
Secondary Effect on Physiological Parameters: Mean Arterial Blood Pressure Mean arterial blood pressure at Baseline which corresponds to 10 minutes before the beginning of the procedure. 10 minutes prior to the beginning of the procedure.
See also
  Status Clinical Trial Phase
Completed NCT01148147 - Intracoronary Adenosine Administration to Prevent Periprocedural Myonecrosis in Elective Coronary Angioplasty Phase 3
Completed NCT04318990 - DIstal vs Proximal Radial Artery Access for Cath N/A
Completed NCT00372671 - Evaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation Participation Phase 3
Completed NCT00264264 - Arterial Closure vs Direct Compression for Hemostasis After PCI - The ACDC Trial N/A
Recruiting NCT01477775 - Customized Choice of Oral P2Y12 Receptor Blocker Phase 4
Recruiting NCT01058057 - Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention (PCI) Study 2 Phase 3
Completed NCT03329261 - Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg Phase 4
Active, not recruiting NCT01028066 - Feeding Education in Patients Submitted to Coronary Angioplasty Phase 3